Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Saved in:
Bibliographic Details
Title: Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.
Authors: Hashimoto K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Sato T; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan. t.sato@med.nagoya-u.ac.jp.; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan. t.sato@med.nagoya-u.ac.jp., Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan., Okuhiro Y; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Sugiyama D; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Zhang H; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ito S; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Inagaki Y; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Morishita T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.; Department of Blood and Marrow Transplantation & Cellular Therapy, Fujita Health University, Toyoake, Japan., Goto T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Fukushima N; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan., Ozeki K; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan., Hanajiri R; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan., Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan., Nishikawa H; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Division of Cancer Immunology, Research Institute / Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo/Chiba, Japan.; Division of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Kindai University Faculty of Medicine, Osaka-sayama, Japan., Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.
Source: Annals of hematology [Ann Hematol] 2026 Mar 02; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 02.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-026-06897-2